Mark T. Fleming, MD

Disclosure information not submitted.

Presentation(s):

• Late-Breaking Abstract: PLLBA-02: Impact of 18F-rhPSMA-7.3 PET on upstaging of patients with prostate cancer recurrence: Results from the prospective, phase 3, multicenter, SPOTLIGHT study

  Friday, May 13, 2022
  10:55 AM – 11:05 AM

• PLLBA-02: Impact of 18F-rhPSMA-7.3 PET on upstaging of patients with prostate cancer recurrence: Results from the prospective, phase 3, multicenter, SPOTLIGHT study

  Friday, May 13, 2022
  11:13 AM – 11:21 AM